Profile: Hande Pharma Limited specializes in research, development of active pharmaceutical ingredients, intermediates and plant extracts. Our product line includes ethyl (3R,S)-2,2-difluoro-3-hydroxy-3-(2,2-dimethyldioxolan-4-yl)propionate, 2-deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate, 2',2'-difluoro-2'-deoxycytidine-3',5'-dibenzoate, gemcitabine base, ethyl bromodifluoroacetate, adefovir dipivoxil, entecavir, intermediates of capecitabine, 4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl), 4-(4-fluorobenzoyl)butyric acid, ezetimibe, faropenem, ertapenem and meropenem.